The latest quarterly R&D expense is $5.03 Million with a QoQ Growth of +22.50%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $5.03M.
$5.03M
$5.03 Million
Q2 FY2026 · 2026-06-30
+22.50%
vs. $4.11M prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $5.03M | +22.50% | -99.86% |
| Q1 FY2026Period end 2026-03-31 | $4.11M | -38.84% | -21.24% |
| Q4 FY2025Period end 2025-12-31 | $6.71M | +130.18% | +246.54% |
| Q3 FY2025Period end 2025-09-30 | $2.92M | -99.92% | +31.16% |
| Q2 FY2025Period end 2025-06-30 | $3.66B | +70154.12% | +80122.98% |
| Q1 FY2025Period end 2025-03-31 | $5.21M | +169.12% | +64.84% |
| Q4 FY2024Period end 2024-12-31 | $1.94M | -12.88% | +7.47% |
| Q3 FY2024Period end 2024-09-30 | $2.22M | -51.30% | +39.67% |
| Q2 FY2024Period end 2024-06-30 | $4.57M | +44.35% | +222.02% |
| Q1 FY2024Period end 2024-03-31 | $3.16M | +75.46% | +156.81% |
| Q4 FY2023Period end 2023-12-31 | $1.80M | +13.23% | +64.19% |
| Q3 FY2023Period end 2023-09-30 | $1.59M | +12.29% | +12.66% |
| Q2 FY2023Period end 2023-06-30 | $1.42M | +15.12% | -2.03% |
| Q1 FY2023Period end 2023-03-31 | $1.23M | +12.17% | +25.84% |
| Q4 FY2022Period end 2022-12-31 | $1.10M | -22.31% | +28.30% |
| Q3 FY2022Period end 2022-09-30 | $1.41M | -2.35% | +79.95% |
| Q2 FY2022Period end 2022-06-30 | $1.45M | +47.87% | +221.29% |
| Q1 FY2022Period end 2022-03-31 | $978.80K | +14.37% | +117.28% |
| Q4 FY2021Period end 2021-12-31 | $855.81K | +8.97% | N/A |
| Q3 FY2021Period end 2021-09-30 | $785.36K | +74.34% | N/A |
| Q2 FY2021Period end 2021-06-30 | $450.48K | -0.00% | N/A |
| Q1 FY2021Period end 2021-03-31 | $450.48K | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
